Individual investors who hold 41% of Palvella Therapeutics, Inc. (NASDAQ:PVLA) gained 12%, insiders profited as well [Yahoo! Finance]
Palvella Therapeutics, Inc. (PVLA)
Company Research
Source: Yahoo! Finance
The top 9 shareholders own 51% of the company Insiders have been buying lately A look at the shareholders of Palvella Therapeutics, Inc. ( NASDAQ:PVLA ) can tell us which group is most powerful. We can see that individual investors own the lion's share in the company with 41% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company. While individual investors were the group that benefitted the most from last week's US$33m market cap gain, insiders too had a 18% share in those profits. Let's delve deeper into each type of owner of Palvella Therapeutics, beginning with the chart below. See our latest analysis for Palvella Therapeutics NasdaqCM:PVLA Ownership Breakdown March 16th 2025
Read more
Impact Snapshot
Event Time:
PVLA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PVLA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PVLA alerts
High impacting Palvella Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
PVLA
News
- Palvella Therapeutics (NASDAQ: PVLA) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $45.00 price target on the stock.MarketBeat
- Palvella Therapeutics (NASDAQ: PVLA) was upgraded by analysts at Jones Trading to a "strong-buy" rating.MarketBeat
- Palvella Therapeutics (NASDAQ: PVLA) is now covered by analysts at Jones Trading. They set a "buy" rating and a $45.00 price target on the stock.MarketBeat
- Palvella Therapeutics to Host Full Year 2024 Financial Results Conference Call on March 31, 2025GlobeNewswire
- Eli Lilly's three-year Ebglyss study leaves 50% of AD patients with clear skin [Yahoo! Finance]Yahoo! Finance